These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22594514)

  • 21. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
    Hopewell JC; Reith C; Armitage J
    Curr Opin Lipidol; 2014 Dec; 25(6):438-45. PubMed ID: 25313593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
    Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
    Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Langmann T
    Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of pharmacogenetic variation on the effects of statins.
    Maggo SD; Kennedy MA; Clark DW
    Drug Saf; 2011 Jan; 34(1):1-19. PubMed ID: 21142270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomic importance of pravastatin.
    Peters B; Maitland-van der Zee AH
    Pharmacogenomics; 2008 Sep; 9(9):1207-10. PubMed ID: 18781848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
    Kerst LL; Mauro VF
    Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
    van der Harst P; Asselbergs FW; Hillege HL; Bakker SJ; Voors AA; van Veldhuisen DJ; van Gilst WH;
    Am J Cardiol; 2007 Nov; 100(10):1548-51. PubMed ID: 17996517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
    Postmus I; Trompet S; Deshmukh HA; Barnes MR; Li X; Warren HR; Chasman DI; Zhou K; Arsenault BJ; Donnelly LA; Wiggins KL; Avery CL; Griffin P; Feng Q; Taylor KD; Li G; Evans DS; Smith AV; de Keyser CE; Johnson AD; de Craen AJ; Stott DJ; Buckley BM; Ford I; Westendorp RG; Slagboom PE; Sattar N; Munroe PB; Sever P; Poulter N; Stanton A; Shields DC; O'Brien E; Shaw-Hawkins S; Chen YD; Nickerson DA; Smith JD; Dubé MP; Boekholdt SM; Hovingh GK; Kastelein JJ; McKeigue PM; Betteridge J; Neil A; Durrington PN; Doney A; Carr F; Morris A; McCarthy MI; Groop L; Ahlqvist E; ; Bis JC; Rice K; Smith NL; Lumley T; Whitsel EA; Stürmer T; Boerwinkle E; Ngwa JS; O'Donnell CJ; Vasan RS; Wei WQ; Wilke RA; Liu CT; Sun F; Guo X; Heckbert SR; Post W; Sotoodehnia N; Arnold AM; Stafford JM; Ding J; Herrington DM; Kritchevsky SB; Eiriksdottir G; Launer LJ; Harris TB; Chu AY; Giulianini F; MacFadyen JG; Barratt BJ; Nyberg F; Stricker BH; Uitterlinden AG; Hofman A; Rivadeneira F; Emilsson V; Franco OH; Ridker PM; Gudnason V; Liu Y; Denny JC; Ballantyne CM; Rotter JI; Adrienne Cupples L; Psaty BM; Palmer CN; Tardif JC; Colhoun HM; Hitman G; Krauss RM; Wouter Jukema J; Caulfield MJ
    Nat Commun; 2014 Oct; 5():5068. PubMed ID: 25350695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.
    Karlson BW; Barter PJ; Palmer MK; Lundman P; Nicholls SJ
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):697-703. PubMed ID: 22705128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.